| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
1 company
Anders Jack is a Chief Financial Officer at Revolution Medicines, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $19.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $98.00 | $980,000.00 | -8.5% | -6.3% | - | |
| Dec 16, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 3,104 | $77.09 | $239,288.60 | -2.8% | +27.6% | - | |
| Nov 25, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 5,418 | $74.00 | $400,932.00 | -4.7% | +35.8% | - | |
| Nov 11, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $64.00 | $640,000.00 | -8.3% | +51.0% | - | |
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 2,320 | $45.82 | $106,313.77 | -2.0% | +76.7% | - | |
| Sep 3, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $40.10 | $400,992.46 | -4.2% | +89.4% | - | |
| Jun 16, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 2,170 | $39.83 | $86,431.10 | -1.9% | +16.2% | +293.7% | |
| Mar 17, 2025 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 1,864 | $39.04 | $72,771.12 | -1.6% | +1.6% | +153.3% | |
| Dec 16, 2024 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 2,635 | $45.40 | $119,639.01 | -2.7% | -12.5% | +73.5% | |
| Oct 11, 2024 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $50.30 | $502,979.00 | -9.2% | -17.2% | -4.4% |